The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Joanna J. Wykrzykowska
Showing 1-20 of 63 articles
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial
van Ginkel DJ,
Bor WL,
Dubois CL,
Aarts HM,
Rooijakkers MJ,
van Bergeijk KH,
Rosseel L,
Veenstra L,
De Backer O,
Van Mieghem NM,
van der Kley F,
Wilgenhof A,
Leonora R,
Halim J,
Schotborgh CE,
Barbato E,
Van Der Heyden JA,
Frambach P,
Ferdinande B,
Mylotte D,
Fabris E,
Rensing BJ,
Timmers L,
Swaans MJ,
Brouwer J,
Nijenhuis VJ,
Peper J,
Vriesendorp PA,
de Laat B,
Ninivaggi M,
Stragier H,
Voskuil M,
IJsselmuiden AJ,
Hermanides RS,
Agostoni P,
van 't Hof AW,
Wykrzykowska JJ,
van Royen N,
Delewi R,
ten Berg JM
November 17, 2023 | 10.4244/EIJ-D-23-00206
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg G,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques J,
de Winter R,
Wykrzykowska JJ
March 18, 2022 | 10.4244/EIJ-D-21-00419
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter R,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter R,
Henriques J,
Wykrzykowska JJ
December 4, 2020 | 10.4244/EIJ-D-18-00884
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg G,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Quantitative aortography assessment of aortic regurgitation
Modolo R,
Chang C,
Onuma Y,
Schultz C,
Tateishi H,
Abdelghani M,
Miyazaki Y,
Aben J,
Rutten M,
Pighi M,
El Bouziani A,
van Mourik M,
Lemos PA,
Wykrzykowska JJ,
Brito F,
Sahyoun C,
Piazza N,
Eltchaninoff H,
Soliman O,
Abdel-Wahab M,
Van Mieghem NM,
de Winter R,
Serruys P
October 9, 2020 | 10.4244/EIJ-D-19-00879
Complex PCI: time for a universal definition
Wykrzykowska JJ,
Kerkmeijer L
September 18, 2020 | 10.4244/EIJV16I7A100
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y,
Torii R,
Takahashi K,
Tenekecioglu E,
Asano T,
Chichareon P,
Tomaniak M,
Piek J,
Wykrzykowska JJ,
Bullett N,
Ahmed N,
Al-Lamee R,
Leclerc G,
Kitslaar P,
Dijkstra J,
Reiber J,
Poon E,
Bourantas C,
Gijsen F,
Serruys P,
Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska JJ,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter R,
Serruys P,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y,
Serruys P,
Tenekecioglu E,
Asano T,
Collet C,
Miyazaki Y,
Katsikis A,
Piek J,
Wykrzykowska JJ,
Chevalier B,
Mintz GS,
Stone G,
Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout KE,
Kraak R,
Weevers A,
Piek J,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry
Modolo R,
Chang C,
Tateishi H,
Miyazaki Y,
Pighi M,
Abdelghani M,
Roos M,
Wolff Q,
Wykrzykowska JJ,
de Winter R,
Piazza N,
Richardt G,
Abdel-Wahab M,
Soliman O,
Onuma Y,
Van Mieghem NM,
Serruys P
August 29, 2019 | 10.4244/EIJ-D-19-00362
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber CK,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning A,
Escaned J,
Wykrzykowska JJ,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
Katagiri Y,
Serruys P,
Asano T,
Miyazaki Y,
Chichareon P,
Modolo R,
Takahashi K,
Kogame N,
Wykrzykowska JJ,
Piek J,
Onuma Y
May 20, 2019 | 10.4244/EIJ-D-18-00607
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T,
Jin Q,
Katagiri Y,
Kogame N,
Takahashi K,
Chang C,
Chichareon P,
Wang C,
Shi B,
Su X,
Fu G,
Wu Y,
Zhou X,
Yuan Z,
Wykrzykowska JJ,
Piek J,
Serruys P,
Onuma Y,
Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L,
Dudek D,
Weber-Albers J,
Abizaid A,
Christiansen E,
Muller DW,
Kochman J,
Kołtowski Ł,
Lassen JF,
Wojdyla R,
Wykrzykowska JJ,
Onuma Y,
Daemen J
December 7, 2018 | 10.4244/EIJ-D-18-00491
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska JJ,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter R,
Wykrzykowska JJ,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
1
2
3
…
4
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023